<i>Journal of Gastroenterology and Hepatology</i>｜Novel protein C6ORF120 promotes liver fibrosis by activating hepatic stellate cells through the PI3K/Akt/mTOR pathway

doi:10.12449/JCH2405.gwqkjpwzjj4

Volume 40 Issue 5

May 2024

Turn off MathJax

Article Contents

References

Article Navigation > Journal of Clinical Hepatology > 2024 > 40(5): 1049-1049

PDF( 907 KB)

Journal of Gastroenterology and Hepatology｜Novel protein C6ORF120 promotes liver fibrosis by activating hepatic stellate cells through the PI3K/Akt/mTOR pathway

DOI: 10.12449/JCH2405.gwqkjpwzjj4

Published Date: 2024-05-25

Abstract

FullText(HTML)

References(0)

References

Relative Articles

[1]	Journal of Hepatology｜Protein phosphatase 6 regulates metabolic dysfunction-associated steatohepatitis via the mTORC1 pathway[J]. Journal of Clinical Hepatology, 2025, 41(2): 364-364. doi: 10.12449/JCH2502.gwqkjpwzjj2
[2]	Hepatology｜Hepatocyte-derived MASP1-enriched small extracellular vesicles activate HSCs to promote liver fibrosis[J]. Journal of Clinical Hepatology, 2024, 40(7): 1333-1333. doi: 10.12449/JCH2407.gwqkjpwzjj2
[3]	Journal of Hepatology｜Capsaicin receptor TRPV1 maintains quiescence of hepatic stellate cells in the liver via recruitment of SARM1[J]. Journal of Clinical Hepatology, 2024, 40(3): 508-508. doi: 10.12449/JCH2403.gwqkjpwzjj1
[4]	Journal of Hepatology｜Endothelial POFUT1 controls injury-induced liver fibrosis by repressing fibrinogen synthesis[J]. Journal of Clinical Hepatology, 2024, 40(8): 1537-1537. doi: 10.12449/JCH2408.gwqkjpwzjj1
[5]	Guangfa ZHANG, Yingying CAI, Long LIN, Lei FU, Fan YAO, Meng WANG, Rongzhen ZHANG, Yueqiao CHEN, Liangjiang HUANG, Han WANG, Yun SU, Yanmei LAN, Yingyu LE, Dewen MAO, Chun YAO. Protective mechanism of rhubarb decoction against inflammatory damage of brain tissue in rats with mild hepatic encephalopathy： A study based on the PI3K/AKT/mTOR signaling pathway[J]. Journal of Clinical Hepatology, 2024, 40(2): 312-318. doi: 10.12449/JCH240215
[6]	Journal of Gastroenterology and Hepatology｜Farnesoid X receptor is an important target for the treatment of disorders of bile acid and fatty acid metabolism in mice with nonalcoholic fatty liver disease combined with cholestasis[J]. Journal of Clinical Hepatology, 2023, 39(11): 2523-2523. doi: 10.3969/j.issn.1001-5256.2023.11.gwjpwzjj1
[7]	Journal of Hepatology｜Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimated[J]. Journal of Clinical Hepatology, 2023, 39(2): 407-407. doi: 10.3969/j.issn.1001-5256.2023.02.gwjpwzjj2
[8]	Wentao XIE, Kangkang YU, Qi CHENG, Ning LI. Mechanism of microRNA-223-3p inhibiting hepatic stellate cell activation by targeting microtubule-associated protein 1B[J]. Journal of Clinical Hepatology, 2023, 39(12): 2845-2850. doi: 10.3969/j.issn.1001-5256.2023.12.015
[9]	Journal of Gastroenterology and Hepatology｜A high serum ferritin level increases the risk of death associated with chronic liver diseases[J]. Journal of Clinical Hepatology, 2022, 38(2): 438-438. doi: 10.3969/j.issn.1001-5256.2022.02.gwjpwzjj9
[10]	Jing PENG, Wei YUAN, Sihan YIN, Kewei SUN. Mechanism of NLRP3 inflammasome promoting hepatic stellate cell activation[J]. Journal of Clinical Hepatology, 2022, 38(11): 2611-2615. doi: 10.3969/j.issn.1001-5256.2022.11.035
[11]	Journal of Gastroenterology and Hepatology｜Rifampicin can improve cholestasis in patients with persistent hepatocellular secretory failure[J]. Journal of Clinical Hepatology, 2022, 38(2): 396-396. doi: 10.3969/j.issn.1001-5256.2022.02.gwjpwzjj4
[12]	Zhe SHI, Liyuan ZHOU, Guodong ZHAO, Shugang SUN, Liang XUE. Effect of micro-ribonucleic acid-21 on the malignant biological behavior of cholangiocarcinoma cells by targeting the PTEN/PI3K/Akt pathway[J]. Journal of Clinical Hepatology, 2022, 38(9): 2091-2098. doi: 10.3969/j.issn.1001-5256.2022.09.026
[13]	Yang WenJun, Huo Yi, Peng JianPing. Expression of phosphoinositide 3-kinase,mammalian target of rapamycin,70-k Da ribosomal protein S6 kinase,and interferon-α in umbilical cord blood plasmacytoid dendritic cells in parturients in the immune tolerance stage of hepatitis B virus infection versus normal parturients[J]. Journal of Clinical Hepatology, 2020, 36(8): 1727-1731. doi: 10.3969/j.issn.1001-5256.2020.08.010
[14]	Zhang LiHui, Zhang JianBo, Zhao WenXia. Effect of Huatan Qushi Huoxue prescription on the key proteins of the ADPN/PI3K/Akt signaling pathway in rats with nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2020, 36(4): 835-839. doi: 10.3969/j.issn.1001-5256.2020.04.025
[15]	Ju Di, Li JingTao, Han Man, Wei HaiLiang, Yan ShuGuang, Li Mi, Shi XiaoYan, Chang ZhanJie. Research advances in the influence of hepatic stellate cells on precancerous lesions of liver cirrhosis and hepatocellular carcinoma via the TGFβ1-PI3K/AKT signaling pathway[J]. Journal of Clinical Hepatology, 2018, 34(1): 192-194. doi: 10.3969/j.issn.1001-5256.2018.01.042
[16]	Chen XuXiao, Chen YongJun. PI3K / Akt / mTOR signaling pathway and malignant hepatobiliary tumors[J]. Journal of Clinical Hepatology, 2015, 31(6): 989-991. doi: 10.3969/j.issn.1001-5256.2015.06.040
[17]	Wu ZhangHui, Shen Min, Li Long, Wei Jia. Association between PI3K/Akt/mTOR/p70S6K signaling pathway and hepatic fibrosis[J]. Journal of Clinical Hepatology, 2015, 31(11): 1928-1932. doi: 10.3969/j.issn.1001-5256.2015.11.043
[18]	Yu Yuan, Chen XiaoRong. Role of PI3K /Akt /mTOR signaling pathway in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2014, 30(9): 954-957. doi: 10.3969/j.issn.1001-5256.2014.09.029
[19]	Pan Peng, Liu ShaoNeng. PI3K/Akt signaling pathway and hepatic fibrosis[J]. Journal of Clinical Hepatology, 2013, 29(5): 389-392+396.
[20]	Yu Xia, Sun Qian, Zhang Yi. PI3K/Akt/mTOR signal transduction pathway and digestive system tumors [J]. Journal of Clinical Hepatology, 2010, 26(4): 446-449.

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (220) PDF downloads(18)

Journal of Gastroenterology and Hepatology｜Novel protein C6ORF120 promotes liver fibrosis by activating hepatic stellate cells through the PI3K/Akt/mTOR pathway

DOI: 10.12449/JCH2405.gwqkjpwzjj4

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Journal of Gastroenterology and Hepatology｜Novel protein C6ORF120 promotes liver fibrosis by activating hepatic stellate cells through the PI3K/Akt/mTOR pathway

DOI: 10.12449/JCH2405.gwqkjpwzjj4

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content